BioSpace News Archive

Revolution Medicines, Inc. announced that Mark A. Goldsmith, M.D., Ph.D., the company’s chief executive officer and chairman, will be a featured speaker at the 23rd Annual Needham Healthcare Conference and the Stifel Targeted Oncology Forum.

Blueprint Medicines Corporation, announced that, effective April 1, 2024, the Compensation Committee of Blueprint Medicines’ Board of Directors granted non-qualified stock options to purchase an aggregate of 3,711 shares of its common stock and an aggregate of 1,854 restricted stock units to three new employees under Blueprint Medicines’ 2020 Inducement Plan.

Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced that management will participate in a fireside chat at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10, at 12:45 p.m. ET.

Viridian Therapeutics, Inc. announced that a majority of the independent directors serving on the Compensation Committee of the company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 102,000 shares of the company’s common stock to three new employees on April 1, 2024.

BD, a leading global medical technology company, announced that it will report financial results for its second quarter of fiscal year 2024 on Thursday, May 2, 2024.

ORIC Pharmaceuticals, Inc., a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, announced that management will participate in the following investor conferences in April.

GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced annual financial results for the year ended December 31, 2023.

Travere Therapeutics, Inc., announced that the Company will present eight posters in classical homocystinuria at Society for Inherited Metabolic Disorders in Charlotte, North Carolina from April 14-17, 2024, and Genetic Metabolic Dieticians International in Charlotte, North Carolina from April 17-20, 2024.

Werewolf Therapeutics, Inc. announced the publication of an abstract for an upcoming poster presentation at IMMUNOLOGYTM 2024, the annual meeting of the American Association of Immunologists taking place May 3-7 in Chicago, Illinois.

CareRx Corporation (TSX: CRRX) (“CareRx” or the “Company”), Canada’s leading provider of pharmacy services to seniors living and other congregate care